Virginia’s governor gets into a regional spat over Metro and the Silver Line. The D.C. Council advances one of the nation’s most generous paid leave policies. And a longtime Maryland state senator decides he won't retire amid a fight for his seat.
For years, scientists, administrators and politicians alike have lamented the precipitous decline in U.S. research funding. At the National Institutes of Health — the primary conduit for federal biomedical research funding — the budget for grants has fallen 20 percent since 2004, hitting young scientists hardest. With money tight and competition high, the average age at which a young investigator receives a grant has risen steadily, pushing many young minds out of labs and into the private sector. We talk to leaders in the research and funding fields about the ripple effects of this scientific funding crunch, and explore new ideas about how to boost scientific inquiry, despite the downturn.
- Ronald J. Daniels President, Johns Hopkins University
- Sally Rockey Deputy Director for Extramural Research, National Institutes of Health
- Rebecca Riggins Assistant Professor of Oncology, Georgetown Lombardi Comprehensive Cancer Center
Most Recent Shows
While D.C. has seen great strides in lowering the number of newly diagnosed cases, the fact remains that for every hundred Washingtonians, two are living with HIV.
Ivy City will see its 105-year-old school transformed into a community center and more than 300 rental units and retail space grow around it. But the redevelopment plan isn’t sitting well with residents.
D.C. Mayor Muriel Bowser says that homeless people come from outside the district to take advantage of a city policy that guarantees shelter on freezing nights, a cost she says the district can no longer afford.